UDG Healthcare is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 9,000 people with operations in 25 countries and delivering services in over 50 countries.
UDG Healthcare plc operates across two divisions: Ashfield and Sharp.
Ashfield is a global leader in advisory, communication, commercial and clinical services. Ashfield helps improve lives by supporting well-informed conversations with healthcare professionals, payers and patients.
Ashfield is the largest division of UDG Healthcare by profit contribution, and has grown rapidly over recent years. Ashfield focuses on supporting healthcare professionals and patients at all stages of the product life cycle. As a global leader in commercialisation services, Ashfield works with global pharmaceutical and healthcare clients, providing multi-channel communication strategies, sales, marketing, patient engagement and medical services.
Sharp is a global leader in contract packaging and clinical trial supply chain solutions services. Sharp has over1,800 employees, working from nine different locations, with a shared vision of delivering world-class services in clinical trial, commercial packaging, design and technology services for our global pharma clients.
- Top 30 pharma companies are all customers
- $1,028.5 million 2017 net revenue
- $129.3 million 2017 operating profit
- 30+ years dividend growth
08 August 2018
UDG Healthcare has today announced the sale of its Aquilant division to H2 Equity Partners. Click here for more inf… https://t.co/B2qBfWH0nX
- 31 July 2018
18 July 2018
RT @Sharp_Services: At Sharp, our values describe what is important to us as an organization & create an environment that will enable us to…